Cambridge Polymer Group receives a U.S. patent allowance for injectable hydrogel

Share this story with your network

Cambridge Polymer Group received a U.S. patent allowance for its injectable hydrogel formulations for biomedical applications. The patent addresses methods for preparing a biocompatible liquid that gels in vivo without chemical reaction. CPG is developing this technology for nucleus pulposus augmentation, orthopedic applications, synthetic tissue models, and tissue bulking.

Leave a Comment

Your email address will not be published. Required fields are marked *

*